Is Krafton's $69 million AI-first shift a sign of things to come?
Krafton's Shift to AI-First Company PUBG maker Krafton is investing ₩100 billion ($69 million) to become an AI-first company. The company plans to invest around ₩30 billion ($20m) a…
From Pilot to Practice: Implementing Photobiomodulation for Dry AMD Across a Retina Service Line - GigWise
Implementing Photobiomodulation for Dry AMD Dry age-related macular degeneration progresses slowly but relentlessly, resulting in meaningf…
EU Tests Reveal Safety Risks in Low-Cost Products from Shein and Temu - Focus on Travel News
EU Tests Reveal Safety Risks in Low-Cost Products EU tests found major safety risks in low-cost products from Shein and Temu, with 69% fai…
What we know about the Alzheimer’s drug Health Canada approved | RCI
Alzheimer's Drug Approved by Health Canada Health Canada has conditionally approved the drug lecanemab to slow early-stage Alzheimer's dis…
Why Israel Lost the Gaza Opinion War
Why Israel Lost the Gaza Opinion War Sacrificial violence crumbles under scrutiny in the modern world. In the war on Gaza, Israel p…
Hong Kong Tennis Open: last China players exit as top seed Bencic progresses
Hong Kong Tennis Open: Last China Players Exit Zhang Shuai and Wang Yafan lost in straight sets, while top seed Belinda Bencic continued h…
A pyrrhic budget victory could land Carney in the legislative hurt…
Uncertain Budget Victory for Carney's Liberals With Budget Day approaching, it remains unclear if Mark Carney's Liberals will secure the n…
Wizz Air Revives $580 Pass and Tests Business Class
Wizz Air Revives $580 Pass and Tests Business Class European budget airline Wizz Air has relaunched its popular ‘All You Can Fly’ membersh…
DHS Agreement Reveals Risks of Using Social Security Data for Voter Citizenship Checks
DHS Agreement Reveals Risks of Using Social Security Data for Voter Citizenship Checks A recently released agreement gives the Department …
Everest Medicines Acquires Exclusive Greater China and Other Asian Country Rights to VIS-101, a Novel Bifunctional Biologic for Serious Eye Disorders
Everest Medicines Acquires Exclusive Rights to Novel Biologic for Eye Disorders Everest Medicines has acquired an exclusive license to dev…